TNFSF11 and osteoporosis: Most of the currently available therapies for osteoporosis, including amino-bisphosphonates, estrogens and selective estrogen receptor modulators (SERMS), and inhibitors for the receptor activator of nuclear factor κB ligand (RANKL), take effect mainly by reducing bone resorption.